Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 0/100

Charles River Laboratories International Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript

Nov 12, 2019 / 05:20PM GMT
Release Date Price: $135.12 (+2.36%)
Erin Elizabeth Wilson Wright;dit Suisse AG
CrÃ;Research Division - Director & Senior Equity Research Analyst

© -

Good afternoon, or good morning, everybody. My name is Erin Wright. I cover life sciences tools and diagnostics at Crédit Suisse. We're happy to have Charles River Laboratories with us today. We have Birgit Girshick. And let me see if I get everything that you do on here, but you're EVP of Discovery and Safety Assessment, Biologics Testing Solutions and Avian Vaccine Services. Hopefully, I got it all there.

Birgit Girshick
Charles River Laboratories International, Inc. - EVP of Discovery & Safety Assessment, Biologics Testing Solutions and Avian Vaccine Services

That is correct.

Questions & Answers

Erin Elizabeth Wilson Wright;dit Suisse AG
CrÃ;Research Division - Director & Senior Equity Research Analyst

© -

So we're happy to have you and, hopefully, you'll offer us some of your expertise here. In general, I did want to give

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot